Published in J Exp Med on August 01, 1993
Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun (1995) 1.70
Role of interferon-gamma in interleukin 12-induced pathology in mice. Am J Pathol (1995) 1.49
Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med (1996) 1.08
Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect Immun (1997) 0.98
HemaMax™, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primates. PLoS One (2012) 0.93
Impact of natural genetic variation on gene expression dynamics. PLoS Genet (2013) 0.93
Interleukin 12: a new clinical player in cytokine therapy. Br J Cancer (1995) 0.90
Bone marrow transplantation helps restore the intestinal mucosal barrier after total body irradiation in mice. Radiat Res (2014) 0.88
Interleukin-12 and interferon-gamma. Do they always go together? Am J Pathol (1995) 0.88
Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice. J Transl Med (2008) 0.86
Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med (1994) 0.86
The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo. J Exp Med (1995) 0.85
Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation. J Hematol Oncol (2014) 0.85
Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. J Clin Invest (1994) 0.85
All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive murine hematopoietic progenitors in vitro. J Exp Med (1994) 0.82
Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis. J Biol Chem (2012) 0.76
Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects. Exp Hematol Oncol (2014) 0.76
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci U S A (1990) 4.60
Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A (1991) 4.48
Identification of a ligand for the c-kit proto-oncogene. Cell (1990) 4.04
Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A (1987) 3.92
Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium. Cell (1990) 3.66
Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol (1991) 3.40
Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 3.19
Mouse hematopoietic stem cells. Blood (1991) 2.07
Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells. J Exp Med (1992) 1.98
Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science (1991) 1.97
A simplified method for enrichment of mouse hematopoietic stem cells. Exp Hematol (1990) 1.96
Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1. Cell (1986) 1.89
Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood (1979) 1.82
Synergism between hemopoietic growth factors (HGFs) detected by their effects on cells bearing receptors for a lineage specific HGF: assay of hemopoietin-1. J Cell Physiol (1985) 1.61
Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Cloning (1990) 1.23
Standardized bioassay for bone marrow colony stimulating factor in human urine: levels in normal man. J Lab Clin Med (1972) 1.16
Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations. Blood (1992) 0.98
Effects of rrSCF on multiple cytokine responsive HPP-CFC generated from SCA+Lin- murine hematopoietic progenitors. Exp Hematol (1991) 0.93
Recent advances in the growth and isolation of primitive human haemopoietic progenitor cells. Cell Prolif (1992) 0.81
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K. Nucleic Acids Res (1994) 1.43
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood (1996) 1.26
TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol (1995) 1.16
Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res (1996) 1.08
Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur J Immunol (1990) 1.08
Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem (1992) 1.05
Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol (1991) 1.04
Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol (1999) 1.03
Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res (1987) 1.02
A new method for detachment of Dynabeads from positively selected B lymphocytes. J Immunol Methods (1992) 1.01
A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood (2000) 1.00
A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett (1997) 0.99
The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro. Blood (1996) 0.98
Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation. Eur J Immunol (1996) 0.96
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow. Blood (2000) 0.96
The effect of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines. Scand J Immunol (1996) 0.95
T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells. J Exp Med (1993) 0.95
Novel role of interleukin 7 in myelopoiesis: stimulation of primitive murine hematopoietic progenitor cells. J Exp Med (1993) 0.94
The B cell antigen CD75 is a cell surface sialytransferase. J Exp Med (1990) 0.92
Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis. Proc Natl Acad Sci U S A (1994) 0.92
Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma. Int J Cancer (1989) 0.91
Thyroid antibodies in blood donors: prevalence and clinical significance. Acta Endocrinol (Copenh) (1984) 0.90
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells. Stem Cells (2000) 0.90
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma. Int J Cancer (2000) 0.89
Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Cancer Res (1994) 0.88
All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors. J Immunol (1995) 0.86
Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol (1987) 0.86
Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice. Eur J Haematol (1999) 0.86
Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med (1994) 0.86
TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis. Stem Cells (1994) 0.86
Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. J Clin Invest (1994) 0.85
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. Br J Cancer (2000) 0.85
Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood (1996) 0.85
Cross-linking of CD53 promotes activation of resting human B lymphocytes. J Immunol (1994) 0.84
Involvement of ICE (Caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes. Scand J Immunol (1997) 0.84
cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation. Eur J Immunol (2000) 0.84
Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens. Eur J Immunol (1989) 0.84
Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis. Exp Cell Res (1999) 0.83
Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma. Br J Cancer (2001) 0.83
RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol (1998) 0.83
Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells. J Immunol (1987) 0.83
Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas. Leukemia (2006) 0.83
Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood (1997) 0.82
All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive murine hematopoietic progenitors in vitro. J Exp Med (1994) 0.82
Retinyl esters in chylomicron remnants inhibit growth of myeloid and lymphoid leukaemic cells. Eur J Clin Invest (1991) 0.81
Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells. Blood (1994) 0.81
cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1. J Cell Physiol (1988) 0.81
Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitro. Exp Hematol (1994) 0.81
The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells. Blood (1996) 0.81
Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells. Blood (1997) 0.81
Cyclic AMP has the ability to influence multiple events during B cell stimulation. Eur J Immunol (1988) 0.81
The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors. Exp Hematol (1994) 0.81
Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes. Eur J Immunol (1992) 0.81
TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro. J Immunol (1996) 0.81
Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues. Oncogene (1997) 0.80
The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas. Int J Cancer (1987) 0.80
Downregulation of c-myc RNA is not a prerequisite for reduced cell proliferation, but is associated with G1 arrest in B-lymphoid cell lines. Exp Cell Res (1987) 0.80
Constitutive expression of c-myc does not relieve cAMP-mediated growth arrest in human lymphoid Reh cells. J Cell Physiol (1993) 0.80
Direct synergistic effects of IL-4 and IL-11 on proliferation of primitive hematopoietic progenitor cells. Exp Hematol (1995) 0.79
Cell-specific expression of human beta-galactoside alpha 2,6-sialyltransferase transcripts differing in the 5' untranslated region. Eur J Biochem (1993) 0.79
Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction. Diagn Mol Pathol (1999) 0.79
A simple subtraction method for the isolation of cell-specific genes using magnetic monodisperse polymer particles. Biotechniques (1994) 0.79
Antibodies to surface IgM and IgD increase the expression of various class II antigens on human B cells. Eur J Immunol (1985) 0.79
Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers. Acta Oncol (1999) 0.79
Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets. Int J Cancer (1988) 0.79
Lineage commitment of CD34+ human hematopoietic progenitor cells. Exp Hematol (1996) 0.79
Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias. Blood (1991) 0.79
Thrombopoietin promotes adhesion of primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-1: role of activation of very late antigen (VLA)-4 and VLA-5. J Immunol (1997) 0.78
Modification of the 'dividing bradycardia' by hypoxia or exercise. Respir Physiol (1984) 0.77
Mannuronan enhances survival of lethally irradiated mice and stimulates murine haematopoiesis in vitro. Scand J Immunol (1997) 0.77
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas. Br J Cancer (1998) 0.77
Retinoic acid induces apoptosis of human CD34+ hematopoietic progenitor cells: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells. Exp Hematol (1999) 0.77
Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro. Blood (1994) 0.77
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplant (1998) 0.77
CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton. Eur J Immunol (1997) 0.77
Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells. Stem Cells (1996) 0.77
Responses of normal and rheumatic human articular chondrocytes cultured under various experimental conditions in agarose. Scand J Rheumatol (1991) 0.76
Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas. Br J Cancer (1998) 0.76
IL-7 stimulates CSF-induced proliferation of murine bone marrow macrophages and Mac-1+ myeloid progenitors in vitro. J Immunol (1994) 0.76
Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis. Exp Hematol (1999) 0.75
Surface IgG subclasses in human B cell lymphomas as revealed by monoclonal antibodies. Clin Exp Immunol (1984) 0.75
Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit. Br J Haematol (1996) 0.75
[Cellular oncogenes. Role in normal cell growth and activation in neoplasms]. Tidsskr Nor Laegeforen (1988) 0.75
[The immunoglobulin gene superfamily]. Tidsskr Nor Laegeforen (1988) 0.75
Haemopoietic progenitor cell differentiation: flow cytometric assessment in bone marrow and thymus. Br J Haematol (1995) 0.75